Ritlecitinib Tosylate | CAS 2192215-81-7 API Manufacturer & Supplier in China

Product Overview

Ritlecitinib Tosylate (CAS 2192215-81-7) represents a highly specialized, small-molecule kinase inhibitor within the modern pharmaceutical and advanced chemical synthesis sectors. Structurally classified as an irreversible inhibitor of Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family, this molecule blocks the adenosine triphosphate (ATP)-binding site to achieve highly selective immunological modulation. It is extensively researched for its technical efficacy in interrupting signaling pathways associated with severe autoimmune and dermatological conditions, such as alopecia areata, ulcerative colitis, and vitiligo, without causing off-target systemic disruptions. As a leading manufacturer of Ritlecitinib Tosylate CAS 2192215-81-7 based in China, Conscientia Industrial utilizes precision organic synthesis, advanced multi-stage column chromatography, and controlled crystallization techniques to secure a premium structural configuration and exceptional chemical homogeneity. Our stable production line generates a rigorous purity profile that completely aligns with the delicate criteria required for global laboratory research, technical trial testing, and advanced pilot-scale development projects.

Technical Specifications

• Product Name: Ritlecitinib Tosylate

• CAS Number: 2192215-81-7

• Category: Pharmaceutical APIs

• Quality Standard: In-House

• Molecular Formula: C22H27N5O4S

• Molecular Weight: 457.55

• Appearance: White to off-white crystalline powder

• Purity (HPLC): ≥98.0%

• Loss on Drying: ≤1.0%

• Residue on Ignition: ≤0.1%

• Heavy Metals: ≤10ppm

• Solubility: Soluble in DMSO and Methanol; slightly soluble in water

• Brand: Conscientia Industrial

• Country of Origin: China

• Availability: In Stock

• Pricing: Competitive price based on order quantity

• Currency: USD

• Molecular Structure:

Why Partner with Conscientia Industrial

• Technical Quality Control: Our manufacturing process follows rigorous analytical protocols to ensure high-grade batch-to-batch consistency for Ritlecitinib Tosylate CAS 2192215-81-7.

• Advanced Analytical Verification: Every single production lot undergoes comprehensive, high-resolution validation using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to guarantee precise chemical identification and absolute peptide or small-molecule purity profiles.

• Full Technical Documentation: We deliver extensive compliance paperwork directly with your order, providing a comprehensive Certificate of Analysis (COA), detailed Material Safety Data Sheet (MSDS), and complete Method of Analysis (MOA) specific to Ritlecitinib Tosylate CAS 2192215-81-7.

• Scalable Production Capacity: Our China facility is equipped with state-of-the-art reactors to support projects ranging from milligram laboratory research to multi-kilogram bulk industrial supply.

• Direct Source Advantage: Operating as an established primary producer ensures you receive Ritlecitinib Tosylate CAS 2192215-81-7 with minimized lead times, transparent pricing, and comprehensive factory-direct technical support.

Packaging & Storage

• Standard Packaging: 100g/aluminum foil bag, 1kg/aluminum foil bag, or 25kg/fiber drum with dual PE protection for chemical integrity.

• Storage Conditions: Store in a tightly closed container in a cool, dry environment. Protected from light and moisture.

• Shelf Life: 24 months when stored under the recommended conditions.

• Safety Handling: This material is a technical-grade chemical intended for industrial production and laboratory research use only.

Our professional international logistics department manages the secure, temperature-controlled distribution of Ritlecitinib Tosylate CAS 2192215-81-7 utilizing expedited global courier networks, reliable air freight, and optimized sea freight routes.

Request a Quote & COA for Ritlecitinib Tosylate CAS 2192215-81-7 Today.